Access by Prescription

Worldwide, an estimated two billion people are unable to reap the full benefits of modern medicine. For reasons that range from high costs to inadequate distribution, they lack access to medications for preventable or treatable diseases such as HIV/AIDS, malaria, pneumonia, and tuberculosis. Global...

Full description

Saved in:
Bibliographic Details
Published inStanford social innovation review Vol. 14; no. 2; p. 61
Main Author Iyer, Jayasree K
Format Magazine Article
LanguageEnglish
Published Stanford Stanford Social Innovation Review, Stanford University 01.04.2016
Subjects
Cost control
Disease prevention
Guidelines
Medical treatment
Performance management
Pharmaceutical industry
Supply chains
United States > US
Online AccessGet full text

Cover

More Information
Summary:Worldwide, an estimated two billion people are unable to reap the full benefits of modern medicine. For reasons that range from high costs to inadequate distribution, they lack access to medications for preventable or treatable diseases such as HIV/AIDS, malaria, pneumonia, and tuberculosis. Global pharmaceutical companies, meanwhile, have both the ability to provide critical medications and an incentive to extend their reach into the regions where those two billion people live. Here are steps that companies typically take when they resolve to create an effective access-to-medicine strategy: 1. Set clear targets. 2. Develop a suitable model. 3. Align expertise with need. 4. Get the pricing right. 5. Build partnerships. 6. Act locally.
Bibliography:content type line 24
ObjectType-Feature-1
SourceType-Magazines-1
ISSN:1542-7099